scispace - formally typeset
K

Karen R. Cleary

Researcher at University of Texas MD Anderson Cancer Center

Publications -  158
Citations -  20952

Karen R. Cleary is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Adenocarcinoma & Metastasis. The author has an hindex of 67, co-authored 158 publications receiving 20453 citations. Previous affiliations of Karen R. Cleary include University of Texas Health Science Center at Houston & University of Florida.

Papers
More filters
Journal Article

Mucinous carcinomas of the colon and rectum. An analysis of 62 stage B and C lesions.

TL;DR: It is speculated that patients with stage B mucinous carcinoma may have a worse prognosis owing to the extra-cellular mucin, which may make a complete surgical extirpation more difficult.
Journal Article

Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases.

TL;DR: The amount of peak I significantly decreased in the order of normal mucosa greater than primary tumors greater than metastases, while the amount ofpeak II did not significantly change among the tissues.
Journal ArticleDOI

Interorgan glutamine metabolism in the tumor-bearing rat.

TL;DR: The effects of progressive malignant disease on gut/liver glutamines metabolism were studied in order to gain further insight into the altered glutamine metabolism that characterizes the host with cancer and to further elucidate the causes and consequences of glutamine depletion in tumor-bearing rats.
Journal ArticleDOI

Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum.

TL;DR: Local excision and postoperative radiotherapy result in adequate local control of early stage adenocarcinoma of the rectum and showed that only tumor stage and margin status were predictors of local recurrence.
Journal ArticleDOI

Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression.

TL;DR: The results indicated that the relative amount of the L-31 lectin increases as the colorectal cancer progresses to a more malignant stage.